Amanita is not Psilocybin
Two distinct compound profiles and risk contexts
Amanita muscaria and psilocybin mushrooms differ fundamentally in active compounds, reported effects and risk profile. This educational comparison clarifies key distinctions.
Interaction concern
Elevated concernGeneral educational visualization, not a medical prediction.
Main cautions
Amanita contains ibotenic acid and muscimol — not psilocybin
Misidentification risk is serious — these are distinct species with different risk profiles
Educational context only. Not a use guide.
Risk signal is a general educational visualization based on profile risk levels and known interaction concerns. It is not a medical prediction.
How risk signal works →Legal status varies by country, state and local regulation. Cards are educational context only. How legal context works
Explore related profiles
Full educational profiles for the substances in this card.
Amanita Muscaria
High-caution fungus with a distinct pharmacological profile from psilocybin mushrooms. Misidentification and ibotenic acid toxicity are serious risks.
Not the same as psilocybin mushrooms — different compounds, different pharmacology, different risk profile
Legal: Legal context varies
Psilocybin Mushrooms
Psilocybin-containing fungi with intense psychological effects, high anxiety potential and serious legal restrictions in most jurisdictions.
Psychological distress, panic reactions and difficult psychological experiences are documented risks — particularly at higher exposures
Legal: Restricted / controlled
Related comparison
Structured side-by-side comparison relevant to this card.
Educational information only. Not medical advice. Risk signal is a general educational visualization — not a medical prediction. Cards are not use guides or recommendations.